318. シトリン欠損症 Citrin deficiency Clinical trials / Disease details
臨床試験数 : 2 / 薬物数 : 2 - (DrugBank : 2) / 標的遺伝子数 : 0 - 標的パスウェイ数 : 0
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | JPRN-jRCTs041190017 | 31/07/2012 | 10/04/2019 | Confirmation of effects of medium chain triglyceride therapy for citrin deficiency | Confirmation of effects of medium chain triglyceride therapy for citrin deficiency, especially in patients with symptomatic post neonatal intrahepatic cholestasis and that with adult-onset type II citrullinemia | citrin deficiency Endocrinology and Metabolism, Pediatrics;D006111 | Medium chain triglyceride 5-15ml 3 times a day | Mitsui Tetsuo | NULL | Recruiting | Not applicable | 80age | Both | 50 | Phase 2 | Japan |